Quinsam Capital Corporation (CSE:QCA) issued an update on a variety of new investments the company has made to shareholders.
As quoted in the press release:
Roger Dent, CEO of Quinsam said “We continue to deploy the funds from our recent new issues. This group of investments includes some transactions that we expect to have a very high profile as time goes on.”
US$1.25 Million Invested in FLRish
Quinsam invested US$1.25 million in Oakland-based FLRish as part of a US$6.5 million Series A financing that also included Cresco Capital Partners and Murray Field & Co. FLRish is regarded by many as a pioneer in the California cannabis market. It manages the two Harborside retail dispensaries and brands, and as well has a large cannabis cultivation facility. The dispensaries are located in Oakland and San Jose. The new capital will be used to continue building out the firm’s cultivation facility, expand its retail platforms and for corporate development purposes.
US$992,000 Invested in Acreage Holdings
We invested US$992,000 in Acreage Holdings, which has perhaps the largest collection of licenses that exists in the United States. Acreage recently attracted attention when it announced that John Boehner, former Speaker of the House, and Bill Weld, former Massachusetts Governor, would be joining its board of advisors. We expect Acreage to pursue a public listing in 2018.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .